Plasma as a tool to address the current challenges in agriculture

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

According to the researchers’ presentations, plasma application can increase water uptake by crops, reduce irrigation water consumption, and also act as an antibacterial and antifungal tool.

Read more

CIC bioGUNE leads a study showing that multi-omic data can identify silent and stable risk profiles in healthy individuals

by CIC bioGUNE

The study, conducted using local cohorts from the Basque Country, demonstrates how the bioinformatic integration of genetic, metabolomic, and lipoproteomic data allows for the early identification of ...

Read more

New ESMO Clinical Guidelines for the diagnosis and treatment of hepatocellular carcinoma

by Fundació Clínic per a la Recerca Biomèdica

The European Society for Medical Oncology (ESMO) has published a new clinical practice guideline for the diagnosis, treatment, and follow-up of hepatocellular carcinoma (HCC), the main type of liver c...

Read more

New Inmunotherpay strategy in non-clear cell renal cell cancer

by VHIO

The phase 2 international multicenter SUNNIFORECAST study is the first prospective randomized trial evaluating dual immunotherapy with ipilimumab plus nivolumab against standard-of-care (SOC) tyrosine...

Read more

BeCytes opens new laboratory to accelerate the production of in vitro cellular models

by Parc Científic de Barcelona

BeCytes Biotechnologies opens a new laboratory in the Barcelona Science Park (PCB) with the aim of boosting its international growth. The biotechnology company focuses its activity on the management o...

Read more

ANACONDA Biomed Receives CE Mark for Its ANA5 Funnel Catheter to Treat Ischemic Stroke

by Ysios Capital

The CE marking confirms that the ANA5 device complies with the European Union’s health, safety, and environmental protection standards, enabling its eventual commercial viability across the EU.

Read more

Fundación MEDINA presenta en Boston m3DinAI, una Nueva Plataforma de Cribado de Fármacos Antitumorales

by MEDINA

Fundación MEDINA presenta en Boston m3DinAI, una Nueva Plataforma de Cribado de Fármacos Antitumorales

Read more

Un nuevo enfoque terapéutico para el cáncer de pulmón con mutaciones en KRAS

by Professional Newco

El proyecto propone la inhibición de las proteínas ETV4 y ETV5, miembros de la familia PEA3, como complemento a los inhibidores de KRAS. El objetivo es superar la resistencia que limita la eficacia ...

Read more

Hacia una mejor comprensión de los mecanismos responsables del avance del alzhéimer en el cerebro

by Universidad de Málaga

Con este estudio se ha constatado que la muestras cerebrales de pacientes de alzhéimer contienen unas isoformas patogénicas del péptido beta-amiloide que favorecen en mayor medida la formación de ...

Read more

A study on chronic lymphocytic leukaemia identifies a balance of epigenetic forces that can predict clinical course

by Fundació Clínic per a la Recerca Biomèdica

A study led by the Clinic-IDIBAPS, in collaboration with an international team, proposes a new epigenetic model to predict the clinical behaviour of leukaemia patients.

Read more

El alcohol y el síndrome metabólico, principales causas del carcinoma hepatocelular en España

by CIBEREHD-Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

El carcinoma hepatocelular (CHC) es el sexto tumor más frecuente en el mundo El estudio multicéntrico Evolving Epidemiology of HCC in Spain, concluye que el consumo de alcohol representa el 55% de l...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream